Anavex Life Sciences Corp. (AVXL)
3.34
-0.02
(-0.60%)
USD |
NASDAQ |
May 06, 16:00
3.325
-0.02
(-0.45%)
After-Hours: 20:00
Anavex Life Sciences Market Cap : 309.52M for May 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Becton, Dickinson & Co. | 41.18B |
| Nephros, Inc. | 34.27M |
| Cabaletta Bio, Inc. | 415.23M |
| Marker Therapeutics, Inc. | 24.34M |
| ACADIA Pharmaceuticals, Inc. | 3.662B |
Market Cap Related Metrics
| Price to Book Value | 2.444 |
| Price | 3.34 |
| Earnings Yield | -13.92% |